Skip to main content
ADIM logo

ADIM — Investor Relations & Filings

Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,804 across all filing types
Latest filing 2019-05-02 Share Issue/Capital Cha…
Country TW Taiwan
Listing TW 4142

About ADIM

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
公告本公司辦理註銷庫藏股減資變更登記完成
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (929 characters) from a company (國光生) regarding the completion of a capital reduction registration due to cancellation of treasury shares. It includes specific dates of approval and registration, details on capital amounts before and after reduction, and the number of shares cancelled. There is no detailed financial report or analysis, only a regulatory disclosure of a capital change event. The document is not a full financial report, earnings release, or management discussion. It fits the category of Share Issue/Capital Change announcements, which cover changes in capital structure such as share cancellations and capital reductions.
2019-05-02 Chinese
108年4月變更登記
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about the company's capital structure, including authorized capital, paid-in capital, capital increases and decreases, and share conversions. It is a structured disclosure of share capital changes and related corporate actions. The document is short (837 characters) and does not contain financial statements or management discussion. It is not an announcement of a report publication but a direct disclosure of capital changes. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2019-05-01 Chinese
公告本公司國內第二次有擔保轉換公司債轉換價格調整事宜
Capital/Financing Update Classification · 95% confidence The document is a short announcement (695 characters) from a company regarding an adjustment in the conversion price of a domestic secured convertible bond. It includes specific details about the bond price adjustment and references a cash capital increase. There is no financial statement, comprehensive report, or detailed analysis present. The document is a regulatory announcement about a capital structure change related to convertible bonds, which fits the Capital/Financing Update category. It is not a full report, nor a simple notification of report publication. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-04-26 Chinese
公告本公司國內第一次有擔保轉換公司債轉換價格調整事宜
Capital/Financing Update Classification · 95% confidence The document is a short announcement (695 characters) from a company about an adjustment in the conversion price of a domestic secured convertible bond. It includes specific dates and details about the price adjustment and capital increase but does not contain financial statements or detailed financial analysis. It is a regulatory announcement about a capital structure change related to convertible bonds, which fits the Capital/Financing Update category. The document is not a full report, nor is it a certification or voting result. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-04-26 Chinese
公告本公司108年03月份自結財務報表中，高流動性資產及短 期借款等相關資訊
Regulatory Filings Classification · 95% confidence The document is a short announcement (858 characters) from a company (國光生) providing financial information for March 2019 (108/03 in Taiwanese calendar) including cash, short-term borrowings, and other liquidity-related data. It references compliance with a Taiwan Stock Exchange letter and provides specific financial figures but does not contain comprehensive financial statements or detailed analysis. The document is a regulatory disclosure of interim financial data rather than a full interim or annual report. It is not a full financial report but a regulatory filing of financial information. Therefore, it fits best under Regulatory Filings (RNS).
2019-04-26 Chinese
公告本公司訂定107年現金增資之認股期間事宜(確定代收及 存儲股款銀行)
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the details of a cash capital increase (現金增資) including subscription periods, number of shares issued, pricing, rights, and related procedural information. It includes specifics such as the number of shares, subscription price, subscription rights, and the use of proceeds. The document is short (1567 characters) and is a formal disclosure of a financing event rather than a full financial report or detailed analysis. It does not contain financial statements or comprehensive financial data. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2019-04-23 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.